We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.06%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.66B
AUM Growth
+$908M
Cap. Flow
+$609M
Cap. Flow %
7.04%
Top 10 Hldgs %
13.15%
Holding
1,050
New
339
Increased
147
Reduced
104
Closed
359

Top Buys

Rank Stock Value
1
WDAY icon
Workday
WDAY
+$130M
2
KSU
Kansas City Southern
KSU
+$79.4M
3
FTV icon
Fortive
FTV
+$74.8M
4
PAYC icon
Paycom
PAYC
+$74.3M
5
CTOS icon
Custom Truck One Source
CTOS
+$68.8M

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$113M
2
ADBE icon
Adobe
ADBE
+$90.8M
3
INTC icon
Intel
INTC
+$70.3M
4
VRT icon
Vertiv
VRT
+$59.9M
5
TJX icon
TJX Companies
TJX
+$53M

Sector Composition

Rank Sector Weight
1 Technology 22.2%
2 Healthcare 16.19%
3 Industrials 14.03%
4 Financials 13.86%
5 Consumer Discretionary 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDWT
551
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$1.46M 0.02%
37,114
-52,727
-59% -$2.32M
SCOB
552
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
$1.46M 0.02%
+150,000
New +$1.47M
POW
553
DELISTED
Powered Brands Class A Ordinary Shares
POW
$1.46M 0.02%
150,000
+60,000
+67% +$586K
GSAQ
554
DELISTED
Global Synergy Acquisition Corp. Class A Ordinary Shares
GSAQ
$1.46M 0.02%
150,000
– –
TWNI
555
DELISTED
Tailwind International Acquisition Corp.
TWNI
$1.45M 0.02%
+150,000
New +$1.46M
IBER
556
DELISTED
Ibere Pharmaceuticals
IBER
$1.45M 0.02%
+150,000
New +$1.46M
NVSA
557
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
$1.45M 0.02%
+150,000
New +$1.46M
BIOT
558
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$1.45M 0.02%
150,000
+60,000
+67% +$583K
HPX
559
DELISTED
HPX Corp.
HPX
$1.43M 0.02%
145,160
– –
IMA
560
ImageneBio Inc
IMA
$64.6M
$1.4M 0.02%
8,333
– –
DIBS icon
561
1stdibs.com
DIBS
$166M
$1.39M 0.02%
+40,000
New +$1.03M
AUTL
562
Autolus Therapeutics
AUTL
$559M
$1.39M 0.02%
208,706
– –
PRAX icon
563
Praxis Precision Medicines
PRAX
$9.98B
$1.37M 0.02%
+5,000
New +$1.79M
MOND
564
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$1.36M 0.02%
140,000
+56,000
+67% +$545K
BDSX icon
565
Biodesix
BDSX
$247M
$1.32M 0.02%
+5,000
New +$1.57M
FSTX
566
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$1.29M 0.01%
+150,000
New +$1.28M
LDTC
567
DELISTED
LeddarTech
LDTC
$1.26M 0.01%
259,206
– –
EMBK
568
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$1.24M 0.01%
+6,250
New +$1.24M
EPHY
569
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$1.22M 0.01%
125,001
– –
EJFA
570
DELISTED
EJF Acquisition Corp. Class A Ordinary Share
EJFA
$1.21M 0.01%
+125,001
New +$1.21M
CLRM
571
DELISTED
Clarim Acquisition Corp. Class A Common Stock
CLRM
$1.15M 0.01%
119,001
+47,601
+67% +$464K
GLUE icon
572
Monte Rosa Therapeutics
GLUE
$1.36B
$1.14M 0.01%
+50,000
New +$1.02M
TLIS
573
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$1.1M 0.01%
6,667
+3,334
+100% +$566K
CFRX
574
DELISTED
ContraFect Corporation
CFRX
$1.1M 0.01%
3,125
– –
QTTB icon
575
Q32 Bio
QTTB
$463M
$1.09M 0.01%
+8,333
New +$1.04M
21 22
23
24 25

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2021 Portfolio in Review

As of Q2 2021, Alyeska Investment Group held 1,050 positions worth $8.66B, up 12% from $7.75B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Alyeska Investment Group deployed $609M of net new capital in Q2 2021, opening 339 new positions and adding to 147 existing holdings. Its largest new stake was Workday: 542,446 shares worth $130M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Salesforce, an estimated $113M trimmed.

  • Alyeska Investment Group's largest Q2 2021 buy was Workday: 542,446 shares worth $130M.
  • Alyeska Investment Group added most to Paycom in Q2 2021, an estimated $74.3M increase.
  • Alyeska Investment Group's biggest Q2 2021 reduction was Salesforce, cutting an estimated $113M.
  • Alyeska Investment Group fully exited Paramount Global Class B in Q2 2021, selling an estimated $51.8M.
  • Alyeska Investment Group's ten largest holdings make up 13% of its $8.66B portfolio in Q2 2021.
  • Alyeska Investment Group opened 339 new positions and closed 359 in Q2 2021.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $8.66B.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.